|
PhosphoSolutions
nmda receptor nr2a ![]() Nmda Receptor Nr2a, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/Anti-NMDA+NR2A+Subunit+Antibody/pmc11629444-59-1-16 Average 96 stars, based on 1 article reviews
nmda receptor nr2a - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Addgene inc
pci sep nr2a ![]() Pci Sep Nr2a, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/pCI-SEP_NR2A+(Plasmid+%2323997)/pmc07665045-248-11-6 Average 93 stars, based on 1 article reviews
pci sep nr2a - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
pci egfp nr2a wt ![]() Pci Egfp Nr2a Wt, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/pCI-EGFP-NR2a+wt+(Plasmid+%2345445)/pmc10244591-58-16-18 Average 93 stars, based on 1 article reviews
pci egfp nr2a wt - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Proteintech
glun2a ![]() Glun2a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/NMDAR2A%2FGRIN2A+Antibody/pmc03834217-241-29-32 Average 93 stars, based on 1 article reviews
glun2a - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
anti glun2b ![]() Anti Glun2b, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/GRIN2A+Rabbit+pAb/pmc13460270-94-85-86 Average 94 stars, based on 1 article reviews
anti glun2b - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Alomone Labs
anti nmdar2a glun2a ![]() Anti Nmdar2a Glun2a, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/Anti-NMDAR2A+(GluN2A)+(extracellular)+Antibody/pmc07930753-84-41-49 Average 95 stars, based on 1 article reviews
anti nmdar2a glun2a - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
NeuroMab
mouse anti glun2a ![]() Mouse Anti Glun2a, supplied by NeuroMab, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/Anti-GluN2A-NR2A+Antibody/pmc07480244-116-56-60 Average 94 stars, based on 1 article reviews
mouse anti glun2a - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
PhosphoSolutions
rabbit anti nmdar 2a ![]() Rabbit Anti Nmdar 2a, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/Anti-NMDA+NR2A+Subunit+Antibody/pmc03142562-52-100-111 Average 96 stars, based on 1 article reviews
rabbit anti nmdar 2a - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
PhosphoSolutions
ab133265 ![]() Ab133265, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/Anti-NMDA+NR2A+Subunit+(Tyr1325)+Antibody/pm34433031-221-17-21 Average 96 stars, based on 1 article reviews
ab133265 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Addgene inc
pegfp glun2a ![]() Pegfp Glun2a, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/pEGFP-NR2A+(Plasmid+%2317924)/pmc08714094-33-18-28 Average 92 stars, based on 1 article reviews
pegfp glun2a - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
OriGene
nr2a ![]() Nr2a, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/Grin2a+(NM_008170)+Mouse+Tagged+ORF+Clone/pm36009192-48-12-26 Average 90 stars, based on 1 article reviews
nr2a - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Rockland Immunochemicals
rabbit anti glun2a ![]() Rabbit Anti Glun2a, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nr2a/NMDA+R2A+Antibody/pmc05323044-518-157-161 Average 86 stars, based on 1 article reviews
rabbit anti glun2a - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Neurochemistry
Article Title: Pharmacological target sites for restoration of age‐associated deficits in NMDA receptor‐mediated norepinephrine release in brain
doi: 10.1111/jnc.16280
Figure Lengend Snippet: Characterizing the cellular localization of the NMDA receptors regulating [ 3 H] ‐NE release in young rat cortical brain slices. 1 mM Glu‐stimulated‐[ 3 H]‐NE releases in the cerebral cortex tissue slices from young rats ( n = 3–7) in the presence 1 & 3 μM of the TTX, voltage‐gated Na channel blocker, 10 μM MK‐801, and a combination of MK‐801 and TTX. Data are expressed as mean (±SEM) of net fractional release (stimulated—basal), with each data point representing a duplicate from one animal. Data were analyzed using a mixed‐effect analysis followed by Dunnett's multiple comparison test **** p < 0.0001. NE, norepinephrine; Glu, glutamate; TTX, tetrodotoxin.
Article Snippet: The
Techniques: Comparison
Journal: Journal of Neurochemistry
Article Title: Pharmacological target sites for restoration of age‐associated deficits in NMDA receptor‐mediated norepinephrine release in brain
doi: 10.1111/jnc.16280
Figure Lengend Snippet: The stimulatory effect of Glutamate Vs. NMDA on [ 3 H] ‐NE release in young rat cortical brain slices. In (a), the concentrations‐response curves of glutamate and NMDA‐stimulated [ 3 H] ‐NE releases in the cerebral cortex tissue slices from young rats ( n = 4). In (b), the 1 mM glutamate and NMDA stimulated NE release in the presence and absence of 1.2 mM magnesium in the cerebral cortex tissue slices from young rats ( n = 3). Data were analyzed using an unpaired t ‐test. * p ≤ 0.05, ** p ≤ 0.01 NE, norepinephrine; Glu, glutamate; NMDA, N‐methyl‐ d ‐aspartate; Mg 2+ , magnesium.
Article Snippet: The
Techniques:
Journal: Journal of Neurochemistry
Article Title: Pharmacological target sites for restoration of age‐associated deficits in NMDA receptor‐mediated norepinephrine release in brain
doi: 10.1111/jnc.16280
Figure Lengend Snippet: Age‐associated changes in the expression of NMDA receptors freely solubilize subunits in the cortical rat tissue homogenate. A representative Western blot for NMDA receptors subunits in the cerebral cortex in (a); and in (b) quantified results for GluN1, GluN2A, and GluN2B expressions in young and aged rats ( n = 5). Data are expressed as mean (±SEM) normalized to young rats, with each data point representing a duplicate from one animal. Data were analyzed using an unpaired t ‐test. * p ≤ 0.05. NMDA, N‐methyl‐ d ‐aspartate).
Article Snippet: The
Techniques: Expressing, Western Blot
Journal: Journal of Neurochemistry
Article Title: Pharmacological target sites for restoration of age‐associated deficits in NMDA receptor‐mediated norepinephrine release in brain
doi: 10.1111/jnc.16280
Figure Lengend Snippet: Effect of aging on [ 3 H]‐MK‐801 binding to NMDA receptors in the young (2–3 months old) and aged (18–24 months old) rat cortical tissue membrane. In (a) saturation curve of [ 3 H]‐MK‐801 binding to NMDA receptors in young rats in the presence of 10 μM Glu and Gly ( n = 4). The non‐linear least‐squares fitting of the saturation isotherm yielded K d and B max values of 1.8 nM and 970 fmol/mg of protein, respectively. Both total and non‐specific binding of [ 3 H]‐MK‐801 is shown in the curve, and the specific [ 3 H]‐MK‐801 binding is presented with 95% CI in dotted lines. Inset: Saturation data graphed as Scatchard plots. Whereas in (b), the binding of 10 nM [ 3 H]‐MK‐801 in +/− 10 μM Glu and Gly in young and aged rats ( n = 7), each performed in triplicate and repeated twice. In (c), the % increases after subtracting baseline binding from the binding in the presence of 10 μM Glu and Gly. Baseline Binding values represent [ 3 H]‐MK‐801 binding without exogenous addition of Glu and Gly. Data were analyzed using a Mixed‐effect analysis followed by Tukey's multiple comparison tests. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001; whereas the % of increase over the baseline was analyzed using an unpaired t ‐test: ** p ≤ 0.01. NMDA, N‐methyl‐d‐aspartate; Glu, Glutamate; Gly, Glycine; K d , dissociation constant; B max , Maximum Binding; n H , Hill Coefficient).
Article Snippet: The
Techniques: Binding Assay, Membrane, Comparison
Journal: Frontiers in Neuroscience
Article Title: Altered Light Sensitivity of Circadian Clock in Shank3 +/– Mouse
doi: 10.3389/fnins.2021.604165
Figure Lengend Snippet: Immunostaining for cholera toxin β-subunit (CTB) and NMDAR2A in the suprachiasmatic nucleus (SCN) from wild-type (WT) and Shank3 +/– mice. CTB (diaminobenzidine, DAB, left column ) and NMDAR2A ( right column ) did not show obvious differences in the immunoreactivity between groups (WT, top micrographs ; Shank3 +/– , bottom micrographs ). For this and subsequent figures ( , ), scale bar = 50 μm.
Article Snippet: Primary antibodies were diluted as indicated in 0.1 M PBS containing 1.0% normal serum in 0.3% Triton X-100 [anti-VIP raised in rabbit, CAT 20077, Incstar, 1:2,000 ( ); anti-CTB subunit raised in goat, CAT 703, List Biological Laboratories, 1:2,000 ( );
Techniques: Immunostaining
Journal: The Journal of Neuroscience
Article Title: SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex
doi: 10.1523/JNEUROSCI.2194-19.2020
Figure Lengend Snippet: Sult4a1 knockdown alters synaptic transmission. A , Representative immunoblots of total protein lysates derived from DIV14 rat cortical neurons transduced with a lentivirus expressing shCtrl or shSult4a1. Both conditions were compared with not infected condition (Ni) so as to verify whether the infection itself could cause any alteration of Sult4a1 protein expression. Sult4a1 protein levels were normalized against the level of the not infected neurons (Ni, n = 7 independent cultures; shCtrl, n = 4 independent cultures; shSult4a1, n = 7 independent cultures; one-sample t test: Ni vs shSult4a1, **** p < 0.0001; shCtrl vs shSult4a1, **** p < 0.0001; ns, not significant). B , Representative Western blots of total lysates from shCtrl- or shSult4a1-transduced cortical neurons. Protein levels were normalized against the level of the shCtrl-transduced neurons (shCtrl, n ≥ 3 independent cultures; shSult4a1, n ≥ 3 independent cultures; one-sample t test: GAD65, * p = 0.0396; GluN1, * p = 0.0186). C , Top panels, Representative sEPSCs recorded from shCtrl-transfected (blue) or shSult4a1-transfected (red) neurons. Middle panels, left, Plot of cumulative probability of sEPSC frequencies (shCtrl, n = 5 individual neurons; shSult4a1, n = 5 individual neurons; Kolmogorov–Smirnov test, p = 4 × 10 −18 ); right, mean instantaneous frequencies plot (shCtrl, n = 5 individual neurons; shSult4a1, n = 5 individual neurons; Mann–Whitney test, * p < 0.05; data are shown as the mean ± SEM). Bottom panels, left, Plot of cumulative probability of sEPSC amplitudes (Kolmogorov–Smirnov test, p = 10 −11 ); right, plot of mean sEPSC amplitudes (shCtrl, n = 5 individual neurons; shSult4a1, n = 5 individual neurons; Mann–Whitney test, p = 10 −12 ; data are shown as the mean ± SEM). D , Top panels, Representative sIPSCs recorded from shCtrl-transfected (blue) or shSult4a1-transfected (red) neurons. Middle panels, Left, Plot of cumulative probability of sIPSC frequencies (shCtrl, n = 5 individual neurons; shSult4a1, n = 6 individual neurons; Kolmogorov–Smirnov test, p = 5 × 10 −8 ); right, plot of mean instantaneous frequencies (shCtrl, n = 5 individual neurons; shSult4a1, n = 6 individual neurons; Mann–Whitney test; data are shown as the mean ± SEM). Bottom panels, Left, Plot of cumulative probability of sIPSC amplitudes (Kolmogorov–Smirnov test, p = 10 −12 ); right, plot of mean sIPSC amplitudes (shCtrl, n = 5 individual neurons; shSult4a1, n = 5 individual neurons; Mann–Whitney test, p = 10 −8 ; data are shown as the mean ± SEM).
Article Snippet: The following primary antibodies were used: mouse anti-β-actin (catalog #A5316, Sigma-Aldrich), mouse anti-βIII-tubulin (catalog #MAB1637, Sigma-Aldrich), mouse anti-GABA A Rα1 (catalog #75–136, NeuroMab), mouse anti-GAD65 (catalog #198111, Synaptic System), mouse anti-GAD67 (catalog #sc-28376, Santa Cruz Biotechnology), mouse anti-GFP (catalog #11814460001, Roche), rabbit anti-GluA1 (catalog #AB1504, Millipore), mouse anti-GluA2 (catalog #75–002, NeuroMab), mouse anti-GluN1 (catalog #556308, BD),
Techniques: Knockdown, Transmission Assay, Western Blot, Derivative Assay, Transduction, Expressing, Infection, Transfection, MANN-WHITNEY, Patch Clamp
Journal: Antioxidants (Basel, Switzerland)
Article Title: The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors.
doi: 10.3390/antiox11081471
Figure Lengend Snippet: Figure 2. (A) The chemical structure of ergotamine. (B) The H2O-injected oocytes did not cause any change with the treatment of 100 µM glutamate (n = 6–8 oocytes from four different frogs). (C–F) Glutamate induced inward currents with or without ergotamine (30 µM and 10 µM). For each subunit of NMDARs, the responses after treating with either glutamate (100 µM) alone or together with ergotamine (30 and 10 µM). Voltage clamp recording was conducted at a holding potential of −80 mV. The coapplication of ergotamine with glutamate resulted in modulation of the recombinant receptors (C) NR1a/NR2A, (D) NR1a/NR2B, (E) NR1a/NR2C, and (F) NR1a/NR2D, which in turn reduced glutamate-evoked inward current in a reversible manner (n = 6–8 oocytes from four different frogs).
Article Snippet: The mouse NMDAR subunit cDNAs included the NR1 (GenBank accession number: MR225704),
Techniques: Injection, Recombinant
Journal: Antioxidants (Basel, Switzerland)
Article Title: The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors.
doi: 10.3390/antiox11081471
Figure Lengend Snippet: Figure 3. Computational molecular modeling of ergotamine docked to the human NR1a/NR2A receptor. (A,C) Side views of the docked ergotamine complex with NMDA channel. (B,D) Binding pocket and docking results of ergotamine and NMDA channel, respectively.
Article Snippet: The mouse NMDAR subunit cDNAs included the NR1 (GenBank accession number: MR225704),
Techniques: Binding Assay
Journal: Antioxidants (Basel, Switzerland)
Article Title: The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors.
doi: 10.3390/antiox11081471
Figure Lengend Snippet: Figure 4. Predicted binding mode of ergotamine and all the favorable interactions with several residues in the active site of the human NR1a/NR2A receptor. (A,B) Interaction between ergo- tamine and wild-type NR1a/NR2A. (C) Residues in wild-type NR1a/NR2A receptor interacting with the ergotamine molecule. (D) Change in the interaction distance of ergotamine in mutant-type NR1a/NR2A receptor. Based on the change in this distance, the residue that directly interacts with ergotamine was identified.
Article Snippet: The mouse NMDAR subunit cDNAs included the NR1 (GenBank accession number: MR225704),
Techniques: Binding Assay, Mutagenesis, Residue
Journal: Antioxidants (Basel, Switzerland)
Article Title: The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors.
doi: 10.3390/antiox11081471
Figure Lengend Snippet: Figure 5. The inward current of several mutant types on the glutamate-evoked current of NR1a/NR2A receptor with or without ergotamine. Representative traces of current induced by application of glutamate (100 µM) alone or together with ergotamine (100 µM) for various mutants: (A) mutant 1 (NR1a subunit W167A and NR2A wild-type), (B) mutant 2 (NR1a subunit H168A and NR2A wild-type), (C) mutant 3 (NR1a subunit V169A and NR2A wild-type), (D) mutant 4 (NR1a wild-type and NR2A subunit P435A), (E) mutant 5 (NR1a wild-type and NR2A subunit N466A), and (F) mutant 6 (double mutant-type NR1a subunit V169A and NR2A subunit N466A). Experiments were performed separately, and data were collected from several oocytes (n = 6–8 oocytes from four different frogs).
Article Snippet: The mouse NMDAR subunit cDNAs included the NR1 (GenBank accession number: MR225704),
Techniques: Mutagenesis